Hormozgan opens cold plasma clinics to combat diabetic amputations
Iran inaugurated its 10th and 11th specialized clinics using cold plasma technology for chronic wound treatment on Saturday, marking a significant expansion of a domestically developed medical innovation aimed at preventing limb amputations among diabetic patients.
The new clinics — launched at Khalij-e Fars (Persian Gulf) and Payambar-e Azam (PBUH) hospitals in in Bandar Abbas — were officially opened in the presence of Mohammad Eslami, the head of the Atomic Energy Organization of Iran (AEOI), and Hormozgan Governor General Mohammad Ashuri Taziani.
“The cold plasma technology has a broad spectrum of applications across agriculture, industry, environmental protection, and, importantly, healthcare,” Eslami said at the ceremony.
“This unique technology is the rightful heritage of the Iranian people, and they must benefit from its impacts across all aspects of life.”
Eslami emphasized that the clinical phase of cold plasma therapy for chronic wounds has been successfully completed.
“The equipment is fully Iranian-made, continuously localized, and steadily upgraded based on scientific research by our university experts,” he said. “The third generation of this device was developed within the past two years at the AEOI.”
He added that the technology effectively eliminates pain and suffering for diabetic patients, significantly reduces the risk of amputation, and spares them the financial and emotional burdens associated with chronic wounds.
“With this modern, minimally invasive approach, patients are saying goodbye to pain, hardship, and high treatment costs,” Eslami noted.
According to health officials, chronic wounds — particularly among Iran’s large diabetic population — often lead to amputation without advanced intervention. The new clinics in Hormozgan, a province with high diabetes prevalence, aim to address this urgent public health challenge using cutting-edge, homegrown technology.
The launch marks the latest step in Iran’s push to deploy cold plasma therapy nationwide, reinforcing its strategy of leveraging nuclear and plasma sciences for civilian and humanitarian purposes.